Use of the Vineland‐3, a measure of adaptive functioning, in CLN3-Reference-Cited by-同舟云学术

Use of the Vineland‐3, a measure of adaptive functioning, in CLN3

Published:2021-12-16 Issue: Volume: Page:
ISSN:1552-4825
Container-title:American Journal of Medical Genetics Part A
language:en
Short-container-title:American J of Med Genetics Pt A

Author:

Dang Do An N.¹^ORCID,Thurm Audrey E.²,Farmer Cristan A.²,Soldatos Ariane G.³,Chlebowski Colby E.²,O'Reilly Julie K.²,Porter Forbes D.¹

Affiliation:

1. Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH Bethesda Maryland USA

2. National Institute of Mental Health, NIH Bethesda Maryland USA

3. National Institute of Neurological Disorders and Stroke, NIH Bethesda Maryland USA

Funder

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute of Mental Health

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajmg.a.62607

Reference39 articles.

1. Standardized assessment of behavior and adaptive living skills in juvenile neuronal ceroid lipofuscinosis

2. Neurobehavioral Features and Natural History of Juvenile Neuronal Ceroid Lipofuscinosis (Batten Disease)

3. Human pathology in NCL

4. Assessing Neurocognitive Outcomes in Inborn Errors of Metabolism. (2015).Paper presented at the Proceedings of Meeting held on April 16 2015.https://www.fda.gov/media/96785/download

5. Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The parent and family impact of CLN3 disease: an observational survey-based study;Orphanet Journal of Rare Diseases;2024-03-18

2. Ability change across multiple domains in mucopolysaccharidosis (Sanfilippo syndrome) type IIIA;Molecular Genetics and Metabolism;2024-02

3. Adaptive behavior assessed by Vineland‐3 as comprehensive outcome measure in vanishing white matter;Annals of Clinical and Translational Neurology;2024-01-12

4. Brain proton MR spectroscopy measurements in CLN3 disease;Molecular Genetics and Metabolism;2023-05

5. Increasing precision in the measurement of change in pediatric neurodegenerative disease;Molecular Genetics and Metabolism;2022-09